このエピソードについて
The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance. The top-class speakers of the series include Kay Davies (Oxford), Kevin M. Esvelt (MIT), Caroline Gutjahr (TUM), Henry T. Greely (Stanford), Dirk Inzé (Gent), Greg Newby (Broad Institute), Kai P. Purnhagen (Bayreuth), Pamela C. Ronald (UC Davis) and Jörg Vogel (HIRI/Würzburg).
The lecture series is part of the CAS Research Focus "CRISPR/Cas" . The spokesperson of this Research Focus is Prof. Dr. Eckhard Wolf (LMU).
The lecture series is part of the CAS Research Focus "CRISPR/Cas" . The spokesperson of this Research Focus is Prof. Dr. Eckhard Wolf (LMU).
英語
アメリカ合衆国
文字起こし 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
過去のエピソードを検索
Center for Advanced Studies (CAS) Research Focus CRISPR/Casの以前のエピソードを検索します。
このポッドキャストの他のエピソード
Genome editing gives precise control of the type of genetic modification made to a cell. Hematopoietic stem cells have pharmacologic properties of durability and output that still remain untapped. Matthew Porteus and his group are using genome editing of hematopoietic stem cells to develop new clas…
The evetn is part of the lecture series "Out of the Box: CRISPR/Cas". The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance.
Panel discussion with Dr. Oana Dima, Prof. Dr. Caroline Gutjahr, and Prof. Dr. Kai P. Purnhagen | Moderation: Christoph von Eichhorn. The dicussion is the final event in the lecture series "Out of the Box: CRISPR/Cas".
The lecture series reflects on the consequences of the revolutionary gene editin…
Sickle cell disease is one of the most prevalent diseases worldwide. Even optimal conventional care has demonstrated inferiority compared to curative options such as hematopoietic stem cell transplantation. Gene editing promises an elegant alternative cure to all patients lacking a matched donor, p…
免責: このページに埋め込まれているポッドキャストとアートワークは Center for Advanced Studies (CAS) からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。
